Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
Definium Therapeutics (NASDAQ:DFTX) used a company event to outline its late-stage development plans for DT120, an oral ...
Definium Therapeutics (DFTX) stock rises after supporting White House psychedelic treatment policy. Stifel initiates coverage ...
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
Nurtec ODT (rimegepant) is a prescription drug that’s used to treat and help prevent migraine. Nurtec ODT comes as an orally disintegrating tablet. Nurtec ODT is a brand-name medication. It contains ...
Will the great TV writer ever top his mega hit? He talks us through his new series about the CIA’s attempts to weaponise LSD – and reveals why James Gandolfini called him ‘Satan’ Last week, a plush ...
Different psychedelic drugs have a strikingly similar effect on networks in the brain, finds the most comprehensive analysis so far of the mind-altering substances. The work, published in Nature ...
It’s a modern scientific renaissance: Little more than half a century ago, psychedelics were largely outlawed, squelching emerging research into the mind-opening substances. Today, psychedelics have ...
President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.
An analysis of hundreds of images from several studies shows how hallucinogenic drugs drive activity in various regions of the brain. By Andrew Jacobs As researchers have sought to demonstrate the ...
For a couple of freewheeling years, two young Harvard psychologists have carried on wide-ranging experiments with mind-altering drugs. At the university’s Center for Research in Personality, they sent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results